Bnp Paribas Asset Management Holding S.A. Rhythm Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 421 shares of RYTM stock, worth $38,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
421Holding current value
$38,723% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
63.1MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$620 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$560 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$532 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$516 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$317 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.13B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...